LIMA1 and pancreatic neoplasm: By employing inhibitors for phosphoinositide 3-kinases (PIK3s), ERK and mitogen-activated protein kinase kinase (MEK), knocking down EPLIN in pancreatic cancer cell lines inhibited inhibitors’ effect on cellular migration.